Current report filing

Document and Entity Information

v3.22.1
Document and Entity Information
Apr. 21, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001750149
Document Type 8-K
Document Period End Date Apr. 21, 2022
Entity Registrant Name INHIBIKASE THERAPEUTICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-39676
Entity Tax Identification Number 26-3407249
Entity Address, Address Line One 3350 Riverwood Parkway SE
Entity Address, Address Line Two Suite 1900
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30339
City Area Code (678)
Local Phone Number 392-3419
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value
Trading Symbol IKT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false